Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 6/2010

01-06-2010 | Reconstructive Oncology

Skin-Sparing Mastectomy and Immediate Breast Reconstruction in the Management of Locally Recurrent Breast Cancer

Authors: A. J. Lindford, MBBS, MRCS, T. J. Meretoja, MD, PhD, K. A. J. von Smitten, MD, PhD, T. A. Jahkola, MD, PhD

Published in: Annals of Surgical Oncology | Issue 6/2010

Login to get access

Abstract

Aim

To investigate whether skin-sparing mastectomy (SSM) and immediate breast reconstruction (IBR) is a possible treatment option in selected cases of locally recurrent breast cancer after previous breast-conserving therapy (BCT).

Material and Methods

Sixty consecutive patients were treated by SSM and IBR between 1995 and 2008 for ipsilateral breast tumour recurrence (IBTR). Selection criteria consisted of: IBTR <3 cm size, not infiltrating skin or chest wall, primarily node negative, recurrence >3 years after primary operation, and no metastases. Patient records were analysed retrospectively and follow-up data on patient outcome included.

Results

The reconstruction method consisted of 40 free abdominal flaps, 18 latissimus dorsi (LD) flaps with or without an implant, and two cases of implant only. Twenty-three patients received adjuvant oncological therapy. During median follow-up of 66 months, 11 patients (18%) developed disease relapse, including 6 (10%) local re-recurrences.

Conclusion

IBR is a possible treatment option for patients who develop local recurrence following earlier BCT. Our local re-recurrence rate of 10% compares well with that following salvage mastectomy for IBTR. Of patients, 43% did not actually meet our selection criteria but yet appeared to fare well in terms of outcome. Therefore we should re-evaluate our selection criteria.
Literature
1.
2.
Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy. Cancer. 1989;63:1912–7.CrossRefPubMed
3.
Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320(13):822–8.PubMedCrossRef
4.
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Lancet. 2005;366(9503):2087–106.PubMed
5.
Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328(22):1587–91.CrossRefPubMed
6.
Clemons M, Hamilton T, Mansi J, et al. Management of recurrent locoregional breast cancer: oncologist survey. Breast. 2003;12(5):328–37.CrossRefPubMed
7.
Chen SL, Martinez SR. The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence. Am J Surg. 2008;196(4):495–9.CrossRefPubMed
8.
Carlson GW, Styblo TM, Lyles RH, Jones G, Murray DR, Staley CA, et al. The use of skin sparing mastectomy in the treatment of breast cancer: The Emory experience. Surg Oncol. 2003;12(4):265–9.CrossRefPubMed
9.
Disa JJ, Cordeiro PG, Heerdt AH, Petrek JA, Borgen PJ, Hidalgo DA. Skin-sparing mastectomy and immediate autologous tissue reconstruction after whole-breast irradiation. Plast Reconstr Surg. 2003;111(1):118–24.CrossRefPubMed
10.
Meretoja TJ, Rasia S, von Smitten KA, Asko-Seljavaara SL, Kuokkanen HO, Jahkola TA. Late results of skin-sparing mastectomy followed by immediate breast reconstruction. Br J Surg. 2007;94(10):1220–5.CrossRefPubMed
11.
Jahkola T, Asko-Seljavaara S, von Smitten K. Immediate breast reconstruction. Scand J Surg. 2003;92(4):249–56.PubMed
12.
von Smitten K. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough? J Surg Oncol. 2008;98(8):585–7.CrossRef
13.
14.
Clemons M, Hamilton T, Goss P. Does treatment at the time of locoregional failure of breast cancer alter prognosis? Cancer Treat Rev. 2001;27(2):83–97.CrossRefPubMed
15.
Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C. Ipsilateral breast tumour recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol. 1996;14(1):52–7.PubMed
16.
van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet F, et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM) EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999;35(1):32–8.CrossRefPubMed
17.
Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer. 2002;95(10):2059–67.CrossRefPubMed
18.
Nishimura S, Takahashi K, Akiyama F, Oguchi M, Tada K, Makita M, et al. Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis. Breast Cancer. 2005;12(2):112–7.CrossRefPubMed
19.
Dalberg K, Mattsson A, et al. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Res Treat. 1998;49(1):69–78.CrossRefPubMed
20.
Benson JR, Querci della Rovere G. Ipsilateral breast cancer recurrence. The Breast. 2008;17(1):12–8.CrossRefPubMed
21.
Radan L, Ben-Haim S, Bar-Shalom R, Guralnik L, Israel O. The role of FDG-PET/CT in suspected recurrence of breast cancer. Cancer. 2006;107(11):2545–51.CrossRefPubMed
Metadata
Title
Skin-Sparing Mastectomy and Immediate Breast Reconstruction in the Management of Locally Recurrent Breast Cancer
Authors
A. J. Lindford, MBBS, MRCS
T. J. Meretoja, MD, PhD
K. A. J. von Smitten, MD, PhD
T. A. Jahkola, MD, PhD
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 6/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-0957-8

Other articles of this Issue 6/2010

Annals of Surgical Oncology 6/2010 Go to the issue

Urologic Oncology

Cervical Lymph Node Dissection for Metastatic Testicular Cancer

Hepatobiliary Tumors

Prognostic Significance of c-erbB-2 and Vascular Endothelial Growth Factor in Colorectal Liver Metastases

Bone and Soft Tissue Sarcomas

Are Radical Compartmental Resections for Retroperitoneal Sarcomas Justified?

Melanomas

Utility of FDG PET/CT and Brain MRI in Melanoma Patients with Increased Serum S-100B Level During Follow-up

Gastrointestinal Oncology

Does Metastatic Lymph Node Ratio Really Suit for Prognostic Prediction of the D1 Lymphadenectomy?

Melanomas

Conditional Survival After Surgical Treatment of Melanoma: An Analysis of the Surveillance, Epidemiology, and End Results Database